Grupo 3
Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético
Publicaciones (589)
-
Puyó, PV; Tagarro, A; Garcia-Obregon, S; Bejarano, OV; Moraleda, C; Aragonés, JH; Cancho, EJB; Morros, AF; Galán-Gómez, V; Fernández, LE; Lendinez-Molinos, F; Velasco, BH; Horno, LU; Domínguez-Pinilla, N; Gazquez, JFP; Lozano, CN; Osuna-Marco, M; Marín-Cruz, I; Pastrana, IG; Barandiaran, NGD; Mingo, NG; Rodríguez, RP; Cañete, A; León, MP; Bustamante, SC; Garcíia, MT; Gonzalez-Prieto, A; Solé-Rodríguez, M; Cruz, MG; Soriano-Arandes, A; Mota, M; Pérez-Hoyos, S; Moreno, L; Astigarraga, I.
Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities
PEDIATRIC BLOOD & CANCER. 2024; 71(8): [doi:10.1002/pbc.31120]
-
Huerga, RN; de Diego, IS; Jiménez, CD; Martínez, CM; Kwon, M; García, NP; Calbacho, M; Vicente, AR; Gallardo, PS.
Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective
EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2024; 70: Nº de citas: 1 [doi:10.1016/j.ejon.2024.102584]
-
Carabante, MIB; Bueno, D; García, LA; Torija, IL; Marsal, J; Navarro, JMF; Oficialdegui, MLU; Panesso, M; Molina, B; Bieler, CB; Palomo, P; Martinez, AP; Diaz-de-Heredia, C.
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
Transplantation And Cellular Therapy. 2024; 30(6): Nº de citas: 6 [doi:10.1016/j.jtct.2024.03.019]
-
Salgado, M; Gálvez, C; Nijhuis, M; Kwon, M; Cardozo-Ojeda, EF; Badiola, J; Gorman, MJ; Huyveneers, LEP; Urrea, V; Bandera, A; Jensen, BEO; Vandekerckhove, L; Jurado, M; Raj, K; Wiesch, JSZ; Bailen, R; Eberhard, JM; Nabergoj, M; Hütter, G; Saldaña-Moreno, R; Oldford, S; Barrett, L; Ramirez, MLM; Garba, S; Gupta, RK; Revollo, B; Ferra-Coll, C; Kuball, J; Alter, G; Sáez-Cirión, A; Diez-Martin, JL; Duke, ER; Schiffer, JT; Wensing, A; Martinez-Picado, J.
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study
Lancet HIV. 2024; 11(6): 389-405 Nº de citas: 1 [doi:10.1016/S2352-3018(24)00090-0]
-
Lakhwani S; Rosiñol L; Puig N; Pico-Picos MA; Medina-González L; Martínez-López J; Paiva B; Cedena MT; Oriol A; Ríos-Tamayo R; Blanchard MJ; Jarque I; Bargay J; Moraleda JM; Carrillo-Cruz E; Sureda A; Krsnik I; González E; Casado LF; Martí JM; Encinas C; De Arriba F; Palomera L; Sampol A; González-Montes Y; Motlló C; De La Cruz J; Alonso R; Mateos MV; Bladé J; Lahuerta JJ; San-Miguel J; Hernández MT.
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.
HAEMATOLOGICA. 2024; 109(6): 1909-1917 Nº de citas: 4 [doi:10.3324/haematol.2023.284154]
-
Giménez, Y; Palacios, M; Sanchez-Domínguez, R; Zorbas, C; Peral, J; Puzik, A; Ugalde, L; Alberquilla, O; Villanueva, M; Rio, P; Gálvez, E; Da Costa, L; Strullu, M; Catala, A; Ruiz-Llobet, A; Segovia, JC; Strahm, B; Niemeyer, CM; Belendez, C; Leblanc, T; Lafontaine, DLJ; Bueren, J; Navarro, S.
Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia
Jci Insight. 2024; 9(10): Nº de citas: 4 [doi:10.1172/jci.insight.171650]
-
Sánchez, JMM; Cancho, EJB; Benéitez, D; Payán-Pernía, S; Gimbert, AC; Ruiz-Llobet, A; Salinas, JA; Sebastián, E; Argilés, B; Bermúdez, M; Vázquez, MA; Ortega, MJ; Rubio, ML; Gondra, A; Uriz, JJ; Morado, M; Coll, MT; Duarte, ML; Baro, M; Cervera, A; Recasens, V; Blanes, CG; del Carcavilla, MP; Tallon, M; Espín, AG; Olteanu, FCO; González, P; Pereira, MMD; Cela, E.
Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)
ANNALS OF HEMATOLOGY. 2024; 103(8): 2743-2755 Nº de citas: 2 [doi:10.1007/s00277-024-05788-8]
-
Bazarbachi, AH; Labopin, M; Raiola, AM; Blaise, D; Arcese, W; Santarone, S; Koc, Y; Bramanti, S; Kulagin, A; Kwon, M; Sica, S; Sanz, J; Brissot, E; Nagler, A; Ciceri, F; Mohty, M.
Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party
CANCER. 2024; 130(18): 3123-3136 Nº de citas: 6 [doi:10.1002/cncr.35365]
-
Stock, CNT; Chillón, CJ; Moro, FM; Palomanes, JM; Villaespesa, MP; Santiago, ER; Martín, ER; Rodríguez, AC; Gutiérrez, VG; Jiménez, GM; Jiménez, JL; Puente, PH.
Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia
Frontiers in Oncology. 2024; 14: Nº de citas: 1 [doi:10.3389/fonc.2024.1394648]
-
Wlodarski, MW; Vlachos, A; Farrar, JE; Da Costa, LM; Kattamis, A; Dianzani, I; Belendez, C; Unal, S; Tamary, H; Pasauliene, R; Pospisilova, D; de la Fuente, J; Iskander, D; Wolfe, L; Liu, JM; Shimamura, A; Albrecht, K; Lausen, B; Bechensteen, AG; Tedgard, U; Puzik, A; Quarello, P; Ramenghi, U; Bartels, M; Hengartner, H; Farah, RA; Al Saleh, M; Hamidieh, AA; Yang, W; Ito, E; Kook, H; Ovsyannikova, G; Kager, L; Gleizes, PE; Dalle, JH; Strahm, B; Niemeyer, CM; Lipton, JM; Leblanc, TM.
Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement
Lancet Haematology. 2024; 11(5): 368-382
-
Iacoboni, G; Iraola-Truchuelo, J; O'Reilly, M; Navarro, V; Menne, T; Kwon, M; Martin-Lopez, AA; Chaganti, S; Delgado, J; Roddie, C; Perez, A; Norman, J; Guerreiro, M; Gibb, A; Caballero, AC; Besley, C; Martinez-Cibrian, N; Mussetti, A; Sanderson, R; Luzardo, H; Iyengar, S; Sanchez, JM; Jones, C; Sancho, JM; Barba, P; Latif, AL; Lopez-Corral, L; Hernani, R; Reguera, JL; Sureda, A; Garcia-Sancho, AM; Bastos, M; Abrisqueta, P; Kuhnl, A.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy
Hemasphere. 2024; 8(5): [doi:10.1002/hem3.62]
-
Ríos-Tamayo, R; Lecumberri, R; Cibeira, MT; González-Calle, V; Alonso, R; Domingo-González, A; Landete, E; Encinas, C; Iñigo, B; Blanchard, MJ; Alejo, E; Krsnik, I; Gómez-Bueno, M; Garcia-Pavia, P; Segovia-Cubero, J; Rosiñol, L; Lahuerta, JJ; Martínez-López, J; Bladé, J.
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Cancers. 2024; 16(9): Nº de citas: 3 [doi:10.3390/cancers16091689]
-
Carbonell D; Monsalvo S; Catalá E; Pérez-Corral A; Villegas C; Falero C; Ruano G; Martinez M; Kwon M; Muñoz-Martínez C; Díez-Martín JL; Gayoso J; Anguita J.
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
Blood Transfusion. 2024; 22(3): 239-245 [doi:10.2450/BloodTransfus.542]
-
Bastos-Oreiro, M; Gutierrez, A; Cabero, A; López, J; Villafuerte, P; Jiménez-Ubieto, A; de Oña, R; de la Fuente, A; Navarro, B; Peñalver, J; Martínez, P; Alonso, C; Infante, M; Córdoba, R; Perez-Montero, B; de Oteyza, JP; de Villambrosio, SG; Fernández-Caldas, P; del Campo, R; Belmonte, DG; Diaz-Gálvez, J; Salar, A; Sancho, JM.
Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study
Cancers. 2024; 16(7): Nº de citas: 3 [doi:10.3390/cancers16071285]
-
Bardon-Cancho, EJ; Marco-Sanchez, JM; Beneitez-Pastor, D; Payan-Pernia, S; Llobet, AR; Berrueco, R; Garcia-Morin, M; Belendez, C; Senent, L; Acosta, MJO; Pleguezuelos, IP; Velasco, P; Collado, A; Moreno-Servet, M; Argiles, B; de Soto, IP; Bermudez, MD; Fierrez, EJS; Blanco-alvarez, A; Navarro, PG; Cela, E.
Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with ß-thalassemia
ANNALS OF HEMATOLOGY. 2024; 103(5): 1525-1539 Nº de citas: 2 [doi:10.1007/s00277-024-05694-z]
-
Moya-Alarcón, C; Azanza, JR; Barberán, J; Ferrer, R; Kwon, M; Moreno, A; Rubio-Terrés, C; Gálvez-Santisteban, M.
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. 2024; 22(8): 713-720 Nº de citas: 1 [doi:10.1080/14787210.2024.2327517]
-
de la Iglesia-San Sebastián, I; Carbonell, D; Bastos-Oreiro, M; Pérez-Corral, A; Bailén, R; Chicano, M; Muñiz, P; Monsalvo, S; Escudero-Fernández, A; Oarbeascoa, G; Fernández-Caldas, P; Gómez-Centurión, I; Pion, M; Gayoso, J; Anguita, J; Kwon, M; Díez-Martín, JL; Buño, I; Martínez-Laperche, C.
Digital PCR Improves Sensitivity and Quanti fi cation in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation And Cellular Therapy. 2024; 30(3): 3061-30612 Nº de citas: 5 [doi:10.1016/j.jtct.2023.12.672]
-
Pagani, C; Rusconi, C; Dalla Pria, A; Ravano, E; Schommers, P; Bastos-Oreiro, M; Verga, L; Gini, G; Spina, M; Arcaini, L; Steffanoni, S; Dalu, D; Crucitti, L; Lorenzi, L; Balzarini, P; Cattaneo, C; Bongiovanni, L; Rosenwald, A; Facchetti, F; Bower, M; Ferreri, AJM; Rossi, G; Tucci, A; Re, A.
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study
Blood Advances. 2024; 8(4): 968-977 Nº de citas: 5 [doi:10.1182/bloodadvances.2023010704]